Neuropeptide Y: a potential theranostic biomarker for diabetic peripheral neuropathy in patients with type-2 diabetes.
Noo Ree ChoYeuni YuChang-Kyu OhDai Sik KoKyungjae MyungYoonsung LeeHee Sam NaYun Hak KimPublished in: Therapeutic advances in chronic disease (2021)
In the pathogenesis of DPN, NPY may play a protective role in the peripheral nervous system and may be useful as a biomarker for detecting T2DM DPN.